Search

everythinglearnresearchcommunity

for

Search:↓

Women pay more for the same 5% minoxidil foam than men, but prices for liquid solutions are similar.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Women's facial moisturizers cost more per ounce than men's.

Gender affects wool traits in sheep, with males and females showing differences in skin proteins related to wool growth.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

India is seeing more cases of gender incongruence and changes in how it's understood and managed legally and medically.

Feminizing hormone therapy increases kidney filtration rate.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Hair transplantation is important for transgender patients to enhance their masculine or feminine appearance.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

The conclusion is that sex-verification in sports was harmful and changes have been made to address this.

Men and women with diabetes in Jeddah, Saudi Arabia, experience different symptoms and complications.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Men and women need different facial rejuvenation treatments due to distinct aging processes and anatomical differences.